Literature DB >> 22424245

Chlamydia testing patterns for commercially insured women, 2008.

Guoyu Tao1, Karen W Hoover, Charlotte K Kent.   

Abstract

BACKGROUND: Annual chlamydia screening for sexually active women aged ≤25 years is recommended, and chlamydia testing rates have continuously increased. However, several studies have shown that many providers screen all women of reproductive age in public settings.
PURPOSE: To examine chlamydia testing patterns in private settings for women and young women aged 15-44 years (hereafter referred to as women).
METHODS: A large commercial claims database was used to estimate the chlamydia testing rate for women aged 15-44 years who had reproductive health services in 2008. Such services and tests were identified using diagnostic and procedural codes in 2008.
RESULTS: Of 3.2 million women aged 15-44 years who had reproductive health services in 2008, 19.2% had at least a claim for a sexually transmitted disease (STD), 29.3% for pregnancy, and 81.2% for a gynecologic exam. Of those 3.2 million, 22.3% had chlamydia testing: 34.2% aged 15-25 years vs 18.3% aged 26-44 years. Of the 0.7 million who were tested, 65% were aged 26-44 years, and the reason for the healthcare visit in which their first chlamydia test was performed was an STD for 22.7% and pregnancy for 33.5%.
CONCLUSIONS: In this population of insured women, young women are undertested and older women are overtested for chlamydia. Efforts to improve screening practices should be evaluated. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22424245     DOI: 10.1016/j.amepre.2011.11.013

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  5 in total

1.  Trends in receipt of sexually transmitted disease services among women 15 to 44 years old in the United States, 2002 to 2006-2010.

Authors:  Laura T Haderxhanaj; Thomas L Gift; Penny S Loosier; Ryan C Cramer; Jami S Leichliter
Journal:  Sex Transm Dis       Date:  2014-01       Impact factor: 2.830

2.  Estimating chlamydia screening coverage: a comparison of self-report and health care effectiveness data and information set measures.

Authors:  Christine M Khosropour; Jennifer M Broad; Delia Scholes; Jacquelyn Saint-Johnson; Lisa E Manhart; Matthew R Golden
Journal:  Sex Transm Dis       Date:  2014-11       Impact factor: 2.830

3.  A population-based evaluation of cervical screening in the United States: 2008-2011.

Authors:  Jack Cuzick; Orrin Myers; William C Hunt; Michael Robertson; Nancy E Joste; Philip E Castle; Vicki B Benard; Cosette M Wheeler
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-12-03       Impact factor: 4.254

4.  Building a web-based tool to support clinical decisions in the control of Chlamydia trachomatis and Neisseria gonorrhoeae infections.

Authors:  Kun Zhao; Fasheng Qiu; Guantao Chen
Journal:  BMC Proc       Date:  2013-12-20

5.  The Influence of Screening, Misclassification, and Reporting Biases on Reported Chlamydia Case Rates Among Young Women in the United States, 2000 Through 2017.

Authors:  Emily R Learner; Kimberly A Powers; Elizabeth A Torrone; Brian W Pence; Jason P Fine; William C Miller
Journal:  Sex Transm Dis       Date:  2020-06       Impact factor: 2.830

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.